Reading RPM? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track RPM free→Reading RPM? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track RPM free→QuarterlyIQ Insights · RPM
The full factor breakdown (the numbers behind each rank). The overview page shows the same reads in short form; this is the depth.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 1 of the last 3 quarter-over-quarter moves. Historically, Materials names rated neutral grew net income 56% of the time over the next year (vs 57% for the rest of the cohort, n=1462).
Over the trailing year it converted 1.21x of net income into operating cash flow. Historically, Materials names rated fragile grew net income 46% of the time over the next year (vs 57% for the rest of the cohort, n=988).
Most sensitive to the broad stock market and real (inflation-adjusted) rates.
Not enough signal to read sensitivity to the US dollar, Fed net liquidity (low R² over the window).
3 material management or governance events in the past 24 months, led by executive changes. Historically, Materials names rated neutral grew net income 56% of the time over the next year (vs 54% for the rest of the cohort, n=272).
Not investment advice. As of 2026-06-12.
The next print and the backdrop around it (sector regime and the AI cycle). Context for the path, not a forecast of returns.
EPS estimate $1.89 → $1.92 (+1.5% / 30d). 1 raised, 1 cut, 8 covering analysts.
1 upgrade, 0 downgrades / 30d, 1 maintained. 93% of analysts rate Buy.
1 PT revisions / 30d. Avg target 26.3% above current price.
0 positive, 0 negative / 30d.
via XLB
Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive. Historically, headwind regimes have averaged stronger forward returns than tailwind.
Context label only: describes the market state (e.g. real bear vs narrative panic, healthy uptrend vs late-stage froth). It is not a per-ticker buy/sell signal and does not predict factor performance.
Not investment advice. As of 2026-06-12.